These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27112624)

  • 1. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55.
    Hackl C; Schacherer D; Anders M; Wiedemann LM; Mohr A; Schlitt HJ; Stroszczynski C; Tranquart F; Jung EM
    Ultraschall Med; 2016 Jun; 37(3):290-6. PubMed ID: 27112624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of breast cancer liver metastases in humanized tumour mice using tumour specific contrast agent BR55®.
    Bitterer F; Hornung M; Platz Batista da Silva N; Schlitt HJ; Stroszczynski C; Wege AK; Jung EM
    Clin Hemorheol Microcirc; 2020; 76(4):559-572. PubMed ID: 32924994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
    Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
    PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Resolution Ultrasound Including Contrast-Enhanced Ultrasound (CEUS) for the Detection of Gas Formation during Aspergillus Fumigatus Infection in Mice.
    Echtenacher B; Wege AK; Schardt K; Bitterer F; Gehmert S; Hoffmann P; Stroszczynski C; Jung EM
    Ultraschall Med; 2016 Jun; 37(3):277-82. PubMed ID: 25741669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter Study.
    Bernatik T; Schuler A; Kunze G; Mauch M; Dietrich CF; Dirks K; Pachmann C; Börner N; Fellermann K; Menzel J; Strobel D
    Ultraschall Med; 2015 Dec; 36(6):590-3. PubMed ID: 26544634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft.
    Sugimoto K; Moriyasu F; Negishi Y; Hamano N; Oshiro H; Rognin NG; Yoshida T; Kamiyama N; Aramaki Y; Imai Y
    J Ultrasound Med; 2012 Dec; 31(12):1909-16. PubMed ID: 23197543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.
    Baetke SC; Rix A; Tranquart F; Schneider R; Lammers T; Kiessling F; Lederle W
    Radiology; 2016 Feb; 278(2):430-40. PubMed ID: 26313618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment.
    Grouls C; Hatting M; Rix A; Pochon S; Lederle W; Tardy I; Kuhl CK; Trautwein C; Kiessling F; Palmowski M
    Radiology; 2013 May; 267(2):487-95. PubMed ID: 23360735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study.
    Smeenge M; Tranquart F; Mannaerts CK; de Reijke TM; van de Vijver MJ; Laguna MP; Pochon S; de la Rosette JJMCH; Wijkstra H
    Invest Radiol; 2017 Jul; 52(7):419-427. PubMed ID: 28257340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
    Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
    Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
    Oldenburg A; Albrecht T
    Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases.
    Dănilă M; Popescu A; Sirli R; Sporea I; Martie A; Sendroiu M
    Med Ultrason; 2010 Sep; 12(3):233-7. PubMed ID: 21203602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
    Dörffel Y; Wermke W
    Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
    Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
    Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution ultrasound including elastography and contrast-enhanced ultrasound (CEUS) for early detection and characterization of liver lesions in the humanized tumor mouse model.
    Wege AK; Schardt K; Schaefer S; Kroemer A; Brockhoff G; Jung EM
    Clin Hemorheol Microcirc; 2012; 52(2-4):93-106. PubMed ID: 22975935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.